FDA approves Victoza to reduce risk of major adverse CV events in patients with type 2 diabetes Aug. 28, 2017
GPCR19 agonists patented by Universite de Droit et Sante de Lille, Institut Pasteur de Lille, INSERM Aug. 25, 2017
Obesity compounds begin phase I trials under Zealand and Boehringer Ingelheim collaboration Aug. 23, 2017
RSS